Jeff White

A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days

Charlotte Benson, Jeff White, Johann S. de Bono et al. · British Journal of Cancer · 2006 · 259 citations · Full text

Medicine, Oncology, Pharmacology +14

Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma.

Jeff White, Peter W. Hewett, Dennis Kosuge et al. · PubMed · 2002 · 213 citations

Medicine, Oncology, Pathology +17

New Model for Estimating Glomerular Filtration Rate in Patients With Cancer

Tobias Janowitz, Edward H. Williams, Andrea Marshall et al. · Journal of Clinical Oncology · 2017 · 98 citations · Full text

Medicine, Biostatistics, Oncology +17

Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST)

Johnathan Joffe, Fay Cafferty, Laura Murphy et al. · Journal of Clinical Oncology · 2022 · 59 citations · Full text

Medicine, Oncology, Radiology +17

The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the Testis

Michael Cullen, Robert Huddart, Johnathan Joffe et al. · European Urology · 2020 · 55 citations · Full text

Medicine, Oncology, Pharmacology +17